Refine your search
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Hemalatha, R.
- Effect of Ga3 and Foliar Nutrients along with Biofertilizers on Flower Quality,vase Life and Sucker Production of Anthurium (anthurium Andreanum Lind.) Cv. TROPICAL RED
Abstract Views :414 |
PDF Views:0
Authors
Affiliations
1 Gandhi Krishi Vignana Kendra, Bengaluru Karnataka, IN
2 Gandhi Krishi Vignana Kendra, Bengaluru Karnataka
1 Gandhi Krishi Vignana Kendra, Bengaluru Karnataka, IN
2 Gandhi Krishi Vignana Kendra, Bengaluru Karnataka
Source
The Asian Journal of Horticulture, Vol 8, No 2 (2013), Pagination: 686-689Abstract
An experiment was conducted to investigate the effect of GA3 and foliar nutrients along with bio-fertilizers on flower quality, vase life and sucker production of Anthurium cv. TROPICAL RED. Results showed that NPK @ 30:10:10 at 0.2 per cent foliar spray and GA3 at 100 ppm along with bio-fertilizers (Azospirillum, Phospho-bacteria and VAM each at 2 g per plant) significantly influenced the flower quality, vase life and sucker production of AnthuriumKeywords
Anthurium,GA3,NPK, azospirillum, Phospho-bacteria, VAM
- Prognosticate the Drugs for Multiple Myeloma Patients by Using Gene Expression Technique with Polyclonal And Monoclonal Samples
Abstract Views :176 |
PDF Views:3
Authors
Affiliations
1 Department of Computer Science, Tiruppur Kumaran College for Women, IN
1 Department of Computer Science, Tiruppur Kumaran College for Women, IN
Source
ICTACT Journal on Image and Video Processing, Vol 8, No 3 (2018), Pagination: 1673-1680Abstract
A major protest in cancer treatment is predicting the clinical response to anti-cancer drugs for each individual patient. For complex diseases such as Myeloma, characterized by high inter-patient variance, the implementation of precision medicine approaches is dependent upon understanding the pathological processes at the molecular level. Myeloma is one of the horrible diseases in the world claiming plurality of lives. Accurately predicting drug responses to Myeloma is a most important problem preventing oncologists’ efforts to ensemble the most powerful drugs to treat Myeloma, which is a ischolar_main goal in precision medicine. It entails the design of therapies that are matched for each individual patient. In this article, it considers a review of approaches that have been proposed to tackle the drug sensitivity prediction problem especially with respect to the personalized Cancer therapy. There are a total of 44 drug sensitivity prediction algorithms. In that the gene expression microarrays consistently provided the best predictive power of the individual profiling data sets; however, performance was increased by including multiple, independent data sets. The proposed algorithm surpassed Bayesian Multitask Multiple Kernel Learning (BMMKL) classification which currently represent the state-of-the-art in drug-response prediction and finally passed the gene expression data to Cytoscape for visualization.Keywords
Drug Sensitivity Prediction, Gene Expression Microarrays, Prediction Algorithms.References
- Cancer Research UK, Available at: http://cancerresearchuk.org
- Cell Division and Cancer, Available at: http://www.abpischools.org.uk – cancer cells
- H.T. Madhloom, S.A. Kareem, H. Ariffin, A.A. Zaidan, H.O. Alanazi and B.B. Zaidan, “An Automated White Blood Cell Localization and Segmentation using Image Arithmetic and Automatic Threshold”, Journal of Applied Sciences, Vol. 10, No. 11, pp. 959-966, 2010.
- F. Scotti, “Robust Segmentation and Measurements of White Cells in Blood Microscopic Images”, Proceedings of IEEE Instrumentation and Measurement Technology Conference, pp. 43-48, 2006.
- M. Ghosh, D. Das, C. Chakraborty and A.K. Ray, “Automated Leukocyte Recognition using Fuzzy Divergence”, Micron, Vol. 41, No. 7, pp. 840-846, 2010.
- V. Vapnik and A. Lerner, “Pattern Recognition using Generalized Portrait Method”, Automation Remote Control, Vol. 24, pp. 774-780, 1963.
- V. Vapnik and A. Chervonenkis, “A Note on One Class of Perceptrons”, Automation Remote Control, Vol. 25, pp. 735-739, 1964.
- V.N. Vapnik, “Statistical Learning Theory”, Wiley, 1998.
- A.J. Smola and B. Scholkopf, “A Tutorial on Support Vector Regression”, Statistics and Computing, Vol. 14, pp. 199-222, 2004.
- V. Cherkassky and Y. Ma, “Comparison of Model Selection for Regression”, Neural Computation, Vol. 15, pp. 1691-1714, 2003.
- M. Gonen and A.A. Margolin, “Drug Susceptibility Prediction against a Panel of Drugs using Kernelized Bayesian Multitask Learning”, Bioinformatics, Vol. 30, pp. 566-563, 2014.
- C.S. Grasso et al., “Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma”, Nature Medicine, Vol. 21, No. 6, pp. 555-559, 2015.
- R.H. Shoemaker, “The NCI60 Human Tumour Cell Line Anticancer Drug Screen”, Nature Review Cancer, Vol. 6, No. 10, pp. 813-823, 2006.
- R. Pal et al., “Boolean Relationships among Genes Responsive to Ionizing Radiation in the NCI 60 ACDS”, Bioinformatics, Vol. 21, No. 8, pp. 1542-1549, 2005.
- J. Barretina et al., “The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity”, Nature, Vol. 483, pp. 603-607, 2012.
- W.E.A. Yang, “Genomics of Drug Sensitivity in Cancer (GDSC): A Resource for Therapeutic Biomarker Discovery in Cancer Cells”, Nucleic Acids Research, Vol. 41, pp. 955-961, 2013.
- A. Basu et al., “An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules”, Cell, Vol. 154, No. 5, pp. 1151-1161, 2013.
- J.B. Kim, “Three-Dimensional in Vitro Tissue Culture Models of Breast Cancer-A Review”, Breast Cancer Research and Treatment, Vol. 85, No. 3, pp. 281-291, 2004.
- J.W. Gordon et.al., “Genetic Transformation of Mouse Embryos by Microinjection of Purified DNA”, Proceedings of National Academy of Science of the United States of America, Vol. 77, No. 12, pp. 7380-7384, 1980.
- J.C. Walrath, “Genetically Engineered Mouse Models in Cancer Research”, Advances in Cancer Research, Vol. 106, pp. 113-164, 2010.
- A. Richmond and Y. Su, “Mouse Xenograft Models vs. GEM Models for Human Cancer Therapeutics”, Disease Models and Mechanism, Vol. 1, No. 2-3, pp. 78-82, 2008.
- R.S. Kerbel, “Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans: better than commonly Perceived-but they can be Improved”, Cancer Biology and Theraphy, Vol. 2, pp. 134-139, 2003.
- J.I. Johnson et al., “Relationships between Drug Activity in NCI Preclinical in Vitro and in Vivo Models and Early Clinical Trials”, British Journal of Cancer, Vol. 84, pp. 1424-1431, 2001.
- C.C. Scholz, “Correlation of Drug Response in Patients and in the Clonogenic Assay with Solid Human Tumour Xenografts”, European Journal of Cancer, Vol. 26, No. 8, pp. 901-905, 1990.
- C. Khanna et al., “The Dog as a Cancer Model”, Nature Biotechnology, Vol. 24, No. 9, pp. 1065-1066, 2006.
- B. Haibe-Kains, “Inconsistency in Large Pharmacogenomic Studies”, Nature, Vol. 504, pp. 389-393, 2013.
- J.C. Costello, et al., “A Community Effort to Assess and Improve Drug Sensitivity Prediction Algorithms”, Nature Biotechnology, Vol. 32, No. 12, pp. 1202-1212, 2014.
- Q. Wan and R. Pal, “An Ensemble based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge”, PLoS ONE, Vol. 9, No. 6, pp. 1-7, 2014.
- A.N. Aimi Salihah, M.Y. Mashor and Azian Azamimi Abdullah, “Improving Blast Segmentation of Cute Myelogenous Leukaemia (AML) Images using Bright Stretching Technique”, Proceedings of International Post Graduate Conference on Engineering, pp. 1-5, 2010.
- S. Olalekan Akinola and O. Jephthar Oyabugbe, “Accuracies and Training Times of Data Mining Classification Algorithms: An Empirical Comparative Study”, Journal of Software Engineering and Applications, Vol. 8, pp. 470-477, 2015
- Tanvi Sharma, Anand Sharma and Vibhakar Mansotra, “Performance Analysis of Data Mining Classification Techniques on Public Health Care Data”, International Journal of Innovative Research in Computer and Communication Engineering, Vol. 4, No. 6, pp. 1-5, 2016.
- D. Szklarczyk et al., “STRING v10: Protein-Protein Interaction Networks, Integrated over the Tree of Life”, Nucleic Acids Research, Vol. 43, pp. 447-452, 2015.
- P. Shannon et al., “A Software Environment for Integrated Models of Biomolecular Interaction Networks”, Genome Research, Vol. 13, pp. 2498-2504, 2003.
- N. Sinha and A.G. Ramakrishnan, “Automation of Differential Blood Count”, Proceedings of IEEE International Conference on Convergent Technologies for the Asia-Pacific region, pp. 371-375, 2003.
- National Cancer Institute, “NCI Dictionary of Cancer Terms”, Available at:
- https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid= 561717
- String, Available at: http://string-db.org/
- CyTargetLinker, Available at: http://projects.bigcat.unimaas.nl/cytargetlinker/
- Drugbank, Available at: http://www.drugbank.ca/
- Monosodium Glutamate (MSG) - A Food Additive
Abstract Views :385 |
PDF Views:1
Authors
Affiliations
1 Pathology and Microbiology Division, National Institute of Nutrition, Indian Council of Medical Research, Hyderabad - 500 007, IN
1 Pathology and Microbiology Division, National Institute of Nutrition, Indian Council of Medical Research, Hyderabad - 500 007, IN
Source
The Indian Journal of Nutrition and Dietetics, Vol 57, No 1 (2020), Pagination: 98-107Abstract
Monosodium glutamate (MSG) also known as glutamic acid is a non essential amino acid used as a flavor enhancer worldwide. MSG is found naturally in tomatoes, grapes, cheese, mushrooms and other foods. It is one of the most widely used food additive in commercial foods. Monosodium glutamate is believed to be associated with different health problems viz., obesity, asthma, metabolic disorders, Chinese restaurant syndrome, neurotoxic effects and detrimental effects on the reproductive organs. Literature showed MSG was associated with adverse side-effects particularly in animals including induction of obesity, diabetes, hepatotoxic, neurotoxic and genotoxic effects. Literature showed that increased consumption of monosodium glutamate may be associated with harmful health effects. Further Intensive research is required to explore monosodium glutamate–related molecular and metabolic mechanisms.
Keywords
Monosodium Glutamate, Flavour Enhancer, Food Additive, Chinese Restaurant Syndrome.References
- Bera, T.K., Kar, S.K., Yadav, P.K., Mukherjee, P., Yadav, S. and Joshi, B. Effects of sodium glutamate on human health: Asystematic review. World J. Pharma. Sci., 2017, 5, 139-144.
- Zia, M.S., Hanif, K.R. and Khalil, M. Effect of monosodium glutamate on the serum estrogen and progesterone levels in female rat and prevention of this effect with diltiazem. J. Ayub. Med. Coll. Abbollabad., 2014, 26, 18 -20.
- Xiong, J.S., Branigan, D. and Lim. Peciphering the MSG Controversy. Int. J. Clin. Exp. Med., 2009, 2, 329-336.
- Singh, 2005. Fact or Fiction, The MSG Controversy. 2005 Retrieved from http://nrs.harvard.edu.
- Anonymous. History of Invention and use of MSG. n.d. 2016 Retrieved from http://www.truthinlabelling.org.
- Wijayasekara, K. and Wanaspal, J. Uses, effects and properties of monosodium glutamate (MSG) on food and nutrition. Int. J. Fd. Sci. Nutr., 2017, 2, 132-143.
- Win. C., ed. Principles of Biochemistry. Boston, MA: Brown Pub Co. 1995.
- Yamaguchi, Shizuko, Tokyo University of Agriculture, Japan; Ninomiya, Kumiko, Technical Committee, Umami Manufacturers Association of Japan. What is umami?. Fd. Rev. Int., 1998, 14, 123-138.
- Kazmi, Z., Fathma, I., Perveen, S. and Malik, S.S. Monosodium glutamate: review on clinical reports. Int. J. Fd. Proper., 2012, 1807-1815.
- Husarova, V. and Ostatnikova, D. Monosodium glutamate toxic effects and their implications for human intake: Areview. JMED Res., 2013, 1-13.
- He, K., Du, S., Xun, P., Sharma, S., Wang, H., Zhai, F. and Popkin, B. Consumption of monosodium glutamate in relation to incidence of overweight in Chinese adults: China Health and Nutrition Survey (CHNS), The Am. J. Clin. Nutr., 2011, 93, 1328-1336.
- Hermanussen, M. and Tresguerres, J.A.F. Does high glutamate intake cause obesity?, J. Pediat. Endocrinol.Metabol., 2003, 16, 965-968.
- Collison, K.S., Makhoul, N.J., Inglis, A., Al-Johi, M., Zaidi, M.Z., Maqbool, Z., Saleh, S.M., Bakheet, R., Mondreal, R., Al-Rabiah, R., Shoukri, M., Milgram, N. W. and Al-Mohanna, F.A. Dietary trans-fat combined with monosodium glutamate induces dyslipidemia and impairs spatial memory. Physiol. Behavior., 2010, 99, 334-342.
- Das, R.S. and Ghosh, S.K. Long term effects of monosodium glutamate on spermatogenesis following neonatal exposure in albino mice- A histological study. Nepal Med. Coll. J., 2010, 12, 149-153.
- Kazmi, Z., Fatima, I., Perveen, S. and Malik, S.S. Monosodium glutamate: review on clinical reports. Int. J. Fd. Proper., 2017, 20, 1807-1815. Retrieved from https://www.fssai.gov.in/home/fss-legislation/fss-regulations.html.
- He, K., Zaho, L., Daviglus, M.L., Dyer, A.R., Horn, L.V., Garside, D., Zhu, L., Guo, D., Wu, Y., Zhou, B. and Stamler, J. Association of monosodium glutamate intake with overweight in chinese adults: the INTERMAPstudy. Obesity, 2008, 16, 1875-1880.
- Walker, R. and Lupien, J.R. The safety evaluation of monosodium glutamate. The J. Nutr., 2000, 130, 1049-1052.
- Iwase, M., Yamamoto, M., Lino, K., Ichikawa, K., Shinohara, N., Yoshinari, M. and Fujishima, M. Obesity induced by neonatal monosodium glutamate treatment in spontaneously hypertensive rats: an animal model of multiple risk factors. Hyperten. Res., 1998, 21, 1-6.
- Yang, W.H., Drouin, M.A., Herbert, M., Mao, Y. and Karsh, J. The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study. J. Aller. Clini. Immunol., 1997, 99, 757-762.
- Vautrin, M.D.A. Monosodium glutamate-induced asthma: study of the potential risk of 30 asthmatics and review of the literature. Allergie et Immunologie., 1987, 19, 29-35.
- Henry-Unaeze, H. N. Update on food safety of monosodium I-glutamate (MSG). Pathophysiol., 2017, 24, 243-249.
- Wijayasekara, K. and Wansapala J. Uses, effects and properties of monosodium glutamate (MSG) on food and nutrition. Int. J. Fd. Sci. Nut., 2017, 2, 132-143.
- Kasozi, K.I., Namubiru, S, Kiconco, O., Kinyi, H.W., Ssempijja, F., Ezeonwumelu J.O.C., Ninsiima, H.I. and Okpanachi, A.O. Low concentrations of monosodium glutamate (MSG) are safe in male Drosophila melanogaster. BMC Res. Notes, 2018, 11, 670.
- Fernstrom, J.D. monosodium glutamate in the diet does not raise brain glutamate concentrations or disrupt brain functions. Ann. Nutr. Metabol., 2018, 73, 43-52.
- Zanfirescu, A., Ungurianu, A., Tsatsakis, A.M., Nitulescu, G.M., Kouretas, D., eskoukis, A., Tsoukalas, D., Engin, A.B., Aschner, M. and Margina, D. Areview of the alleged health hazards of monosodium glutamate. Compreh. Rev. Fd. Sci. Fd. Safety, 2019, 18, 1111-1134.